Aarkstore Enterprise--Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review
Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review
Capstone Therapeutics (Capstone ) formerly known as OrthoLogic Corp. is a biotechnology company engaged in the development and commercialization of novel therapies. The lead product candidates of the company are AZX100 and Chrysalin (TP508). It is developing AZX100 to relax smooth muscle which modulates blood pressure and the function of blood vessels, airways, sphinctersthe, gastrointestinal tract and the genitourinary tract. Chrysalin is a novel synthetic 23-amino acid peptide being developed to produce angiogenic and other tissue repair effects by upregulating endothelial nitric oxide synthase which gives an anti-inflammatory effect.
This comprehensive SWOT profile of Capstone Therapeutics provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Capstone Therapeutics, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the company's operations and business divisions.
- Corporate strategy Analyst's summarization of the company's business strategy.
- SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives' employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history
For more information please contact:
http://www.aarkstore.com/reports/Capstone-Therapeutics-CAPS-Financial-and-Strategic-Analysis-Review-53487.html
From:Aarkstore Enterprise
Contact: jessica
Email: jessica@aarkstore.com
Contact:+918149852585
URL: www.aarkstore.com
Aarkstore Enterprise--Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review
By: Pushpanjali
Aarkstore Enterprise--PhotoMedex, Inc. (PHMD) - Financial and Strategic Analysis Review E-mini Trading: Avoid Account Meltdowns CandleStickCrashCourse Floor Trading Secrets Revealed The Strategic Benefits Of A Console Server Switch Samson Paper Holdings Limited (731) - Financial And Strategic Analysis Review Aarkstore Enterprise---mitsubishi Corporation (8058) - Financial And Strategic Analysis Review Aarkstore Enterprise---northern Petroleum Plc (nop) - Financial And Strategic Analysis Review Aarkstore Enterprise---w&t Offshore, Inc. (wti) - Financial And Strategic Analysis Review Delta Petroleum Corporation (dptr) - Financial And Strategic Analysis Review Aarkstore Enterprise---legacy Oil + Gas Inc. (leg) - Financial And Strategic Analysis Review Aarkstore Enterprise---hiroshima Gas Co., Ltd. (9535) - Financial And Strategic Analysis Review Aarkstore Enterprise--- Artumas Group Inc. (agi) - Financial And Strategic Analysis Review Aarkstore Enterprise---denbury Resources Inc. (dnr) - Financial And Strategic Analysis Review
Aarkstore Enterprise--Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review